AKT1 and rheumatoid arthritis: Based on the integration of systems pharmacology, proteomics, transcriptomics, and single-cell transcriptomics, it has been revealed that celastrol may exert immunomodulatory effects and thus treat RA by modulating the PI3K/AKT signaling pathway through the regulation of key targets such as TNF and IL6 149.